HomeOSE • EPA
add
Ose Immunotherapeutics SA
Previous close
€5.60
Day range
€5.52 - €5.73
Year range
€2.71 - €7.31
Market cap
122.56M EUR
Avg Volume
131.07K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 434.50K | -61.46% |
Operating expense | 5.18M | -40.19% |
Net income | -5.57M | 29.39% |
Net profit margin | -1.28K | -83.23% |
Earnings per share | — | — |
EBITDA | -3.53M | 52.27% |
Effective tax rate | 1.20% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.67M | -27.12% |
Total assets | 82.05M | -10.60% |
Total liabilities | 59.08M | -0.07% |
Total equity | 22.98M | — |
Shares outstanding | 20.50M | — |
Price to book | 5.00 | — |
Return on assets | -14.44% | — |
Return on capital | -17.23% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.57M | 29.39% |
Cash from operations | -4.02M | 50.79% |
Cash from investing | -308.50K | -2,470.83% |
Cash from financing | 6.15M | 14.16% |
Net change in cash | 1.83M | 165.57% |
Free cash flow | -2.36M | 23.97% |
About
Founded
Nov 17, 2004
Website
Employees
62